Wrist-Worn nerve stimulator aims to tame atrial fibrillation after ablation

NCT ID NCT06748157

First seen Jun 29, 2026 · Last updated Jul 22, 2026 · Updated 3 times

Summary

This study tests a wrist-worn device called CardiaCare RR2 that stimulates the median nerve to calm irregular heart rhythms after catheter ablation for atrial fibrillation (AF). About 34 adults who have had AF ablation will use the device daily for six months. Half will receive active stimulation, the other half a sham device. The goal is to see if this non-invasive approach can reduce early and later recurrences of AF and related symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CardiaCare RR2 wrist-worn nerve stimulator
What this could lead to
If effective, this non-invasive device could help prevent atrial fibrillation recurrences after ablation without drugs or additional procedures.
What could go wrong
This is a small early-stage trial with only 34 participants. The device may not reduce arrhythmias, and some people may experience discomfort from the stimulation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.